Bone morphogenic protein and TGFB signaling pathways play an important role in the development of central chondrosarcoma and osteosarcoma, suggesting that TGFB inhibitors can be used in targeted therapy of sarcoma.36, 37. Here, TGFB1 is linked to osteosarcoma.